Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu hodnotící studie, časopisecké články, multicentrická studie, validační studie
PubMed
29315488
DOI
10.1111/bjd.16327
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- dráždivá dermatitida diagnóza etiologie MeSH
- inkontinence moči komplikace MeSH
- internacionalita MeSH
- jazyk (prostředek komunikace) * MeSH
- lidé MeSH
- odchylka pozorovatele MeSH
- psychometrie MeSH
- referenční standardy MeSH
- senzitivita a specificita MeSH
- stupeň závažnosti nemoci * MeSH
- terminologie jako téma MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
- multicentrická studie MeSH
- validační studie MeSH
BACKGROUND: Incontinence-associated dermatitis (IAD) is a specific type of irritant contact dermatitis with different severity levels. An internationally accepted instrument to assess the severity of IAD in adults, with established diagnostic accuracy, agreement and reliability, is needed to support clinical practice and research. OBJECTIVES: To design the Ghent Global IAD Categorization Tool (GLOBIAD) and evaluate its psychometric properties. METHODS: The design was based on expert consultation using a three-round Delphi procedure with 34 experts from 13 countries. The instrument was tested using IAD photographs, which reflected different severity levels, in a sample of 823 healthcare professionals from 30 countries. Measures for diagnostic accuracy (sensitivity and specificity), agreement, interrater reliability (multirater Fleiss kappa) and intrarater reliability (Cohen's kappa) were assessed. RESULTS: The GLOBIAD consists of two categories based on the presence of persistent redness (category 1) and skin loss (category 2), both of which are subdivided based on the presence of clinical signs of infection. The agreement for differentiating between category 1 and category 2 was 0·86 [95% confidence interval (CI) 0·86-0·87], with a sensitivity of 90% and a specificity of 84%. The overall agreement was 0·55 (95% CI 0·55-0·56). The Fleiss kappa for differentiating between category 1 and category 2 was 0·65 (95% CI 0·65-0·65). The overall Fleiss kappa was 0·41 (95% CI 0·41-0·41). The Cohen's kappa for differentiating between category 1 and category 2 was 0·76 (95% CI 0·75-0·77). The overall Cohen's kappa was 0·61 (95% CI 0·59-0·62). CONCLUSIONS: The development of the GLOBIAD is a major step towards a better systematic assessment of IAD in clinical practice and research worldwide. However, further validation is needed.
Department of Dermatology Ghent University Hospital Ghent Belgium
Department of Dermatology University of Pisa Pisa Italy
Department of Medicine 2 Vienna General Hospital Vienna Austria
Department of Nursing Masaryk University Faculty of Medicine Brno Czech Republic
Department of Nursing Queen's University Kingston Canada
Department of Nursing Roper Hospital Charleston SC U S A
Department of Nursing University of Valencia Valencia Spain
Department of Surgery Vienna General Hospital Vienna Austria
Department of Urology University of Virginia Charlottesville VA U S A
Development of Care Barmherzige Brüder Austria Vienna Austria
Faculty of Health Sciences University of Southampton Southampton U K
Geriatric and Wound Healing Department APHP Hôpital Rothschild Paris France
School of Nursing and Midwifery Royal College of Surgeons in Ireland Dublin Ireland
School of Nursing Faculty of Health Sciences Queen's University Kingston Canada
School of Nursing Koc University Istanbul Turkey
Scientific Affairs and Education Manager 3M Johannesburg South Africa
Tissue Viability Unit Canberra Hospital ACT Health Canberra Australia
Wond Expertise Centrum Lange Land Ziekenhuis Zoetermeer the Netherlands
Wound Care Center Ghent University Hospital Ghent Belgium
Wound Care King Saud Medical City Riyadh Saudi Arabia
Citace poskytuje Crossref.org